TP-0903,
TP-0903,
1341200-45-0,
TP0903,
Dubermatinib,
TP 0903,
UNII-14D65TV20J,
CHEMBL2022968,
14D65TV20J,
2-((5-chloro-2-((4-((4-methylpiperazin-1-yl)methyl)phenyl)amino)pyrimidin-4-yl)amino)-N,N-dimethylbenzenesulfonamide,
compound 13,
YUAALFPUEOYPNX-UHFFFAOYSA-N,
dubermatinib (proposed INN),
GTPL8863,
SCHEMBL12813478,
EX-A609,
BCP15884,
BDBM50382425,
MFCD28502172,
ZINC84617535,
AKOS026750306,
CS-4281,
SB17174,
AK547241,
DA-45909,
HY-12963,
B5940,
FT-0700169,
S7846,
J-690134,
2-[[5-chloro-2-[4-[(4-methylpiperazin-1-yl)methyl]anilino]pyrimidin-4-yl]amino]-N,N-dimethylbenzenesulfonamide,
2-{[5-chloro-2-({4-[(4-methylpiperazin-1-yl)methyl]phenyl}amino)pyrimidin-4-yl]amino}-N,N-dimethylbenzene-1-sulfonamide,
pinometostat,
A15776,
Benzenesulfonamide, 2-[[5-chloro-2-[[4-[(4-methyl-1-piperazinyl)methyl]phenyl]amino]-4-pyrimidinyl]amino]-N,N-dimethyl-,